Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Oral erythema multiforme related to bronchodilators intake: A report of a case.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: John Wiley & Sons Country of Publication: England NLM ID: 101620385 Publication Model: eCollection Cited Medium: Print ISSN: 2050-0904 (Print) Linking ISSN: 20500904 NLM ISO Abbreviation: Clin Case Rep Subsets: PubMed not MEDLINE
    • بيانات النشر:
      Original Publication: Chichester, UK : John Wiley & Sons
    • نبذة مختصرة :
      Erythema multiforme is a reactive inflammatory mucocutaneous disorder. It is classified into three groups: erythema multiforme minor, major, and oral erythema multiforme. The oral mucosa is mostly involved. The etiology of this lesion varied from bacterial, viral, or fungal infection to drug reaction. The aim was to report a case of oral erythema multiforme related to drug intake, in order to highlight clinical and histological features in addition to therapeutic modalities of drug-induced oral erythema multiforme. A 74-year-old female patient consulted for painful ulcerations in the oral cavity, associated with burning sensation and inability to eat or swallow for the past 8 days. After detailed anamnesis and clinical examination, the diagnosis of oral erythema multiforme related to drug intake was retained. Oral erythema multiforme is a benign inflammatory disorder involving the oral mucosa with pathognomonic clinical and histological features. It may result from viral, bacterial, or fungal infection and from drug intake reaction. The interruption of the implicated molecule associated with symptomatic treatment is the principal therapeutic modalities.
      Competing Interests: The authors declare that they have no conflict of interest.
      (© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
    • References:
      J Dermatol. 1997 Nov;24(11):726-9. (PMID: 9433029)
      Br J Oral Maxillofac Surg. 2008 Mar;46(2):90-5. (PMID: 17767983)
      Dent Clin North Am. 2013 Oct;57(4):583-96. (PMID: 24034067)
      Dermatol Clin. 2003 Jan;21(1):195-205. (PMID: 12622281)
      Ann Afr Med. 2018 Jan-Mar;17(1):43-45. (PMID: 29363636)
      Indian J Pharmacol. 2021 Jul-Aug;53(4):298-300. (PMID: 34414908)
      Oral Dis. 2005 Sep;11(5):261-7. (PMID: 16120111)
      J Oral Maxillofac Pathol. 2012 Jan;16(1):145-8. (PMID: 22434953)
      Medicine (Baltimore). 2021 Apr 30;100(17):e22387. (PMID: 33907086)
      J Oral Pathol Med. 2003 Oct;32(9):507-12. (PMID: 12969224)
      Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Apr;129(4):e224-e229. (PMID: 31926837)
      Oral Surg Oral Med Oral Pathol. 1968 Mar;25(3):366-73. (PMID: 5237470)
      BMC Oral Health. 2022 Mar 24;22(1):90. (PMID: 35331228)
      Clin Case Rep. 2022 Sep 14;10(9):e6331. (PMID: 36177070)
      Front Pediatr. 2021 Jul 29;9:698261. (PMID: 34395342)
    • Contributed Indexing:
      Keywords: drug; erythema multiforme; oral mucosa; reaction
    • الموضوع:
      Date Created: 20220930 Latest Revision: 20240904
    • الموضوع:
      20240904
    • الرقم المعرف:
      PMC9474916
    • الرقم المعرف:
      10.1002/ccr3.6331
    • الرقم المعرف:
      36177070